Frequently Asked Questions About RSV Vaccine for Adults

Two Respiratory Syncytial Virus (RSV) vaccines are approved for adults ages 60 years and older.

  • Arexvy (GSK adjuvanted RSV vaccine)
  • Abrysvo (Pfizer RSV vaccine)

CDC recommends that adults ages 60 years and older may receive RSV vaccination, using shared clinical decision-making (SCDM). This means that health care providers should talk to these individuals about whether RSV vaccination is appropriate for them.